Ian Mortimer

Chief Executive Officer presso XENON PHARMACEUTICALS INC.

Patrimonio netto: 2 M $ in data 31/03/2024

48 anni

Health Technology

Consumer Services

Profilo

Ian C.
Mortimer is currently the President, Chief Executive Officer & Director at Xenon Pharmaceuticals, Inc. He is also a Director at Perimeter Medical Imaging, Inc. and Perimeter Medical Imaging AI, Inc. Mr. Mortimer previously served as an Independent Director at Appili Therapeutics, Inc. from 2017 to 2020.
Prior to that, he was the Chief Financial Officer & Executive Vice President at Arbutus Biopharma Corp.
from 2007 to 2013.
Mr. Mortimer holds an MBA from Queen's University and an undergraduate degree from the University of British Columbia.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
XENON PHARMACEUTICALS INC. 0.06%	11/03/2024	45 602 ( 0.06% )	2 M $	31/03/2024
PERIMETER MEDICAL IMAGING AI INC 0.17%	03/04/2024	113 333 ( 0.17% )	73 440 $	31/03/2024

Posizioni attive di Ian Mortimer

Società	Posizione	Inizio
XENON PHARMACEUTICALS INC.	Chief Executive Officer	03/06/2021
PERIMETER MEDICAL IMAGING AI, INC.	Director/Board Member	03/07/2020
Xenon Pharmaceuticals USA, Inc. Xenon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Xenon Pharmaceuticals USA, Inc. develops clinical-stage biopharmaceutical products. The company is headquartered in Boston, PA.	President	-

Tutte le posizioni attive di Ian Mortimer

Precedenti posizioni note di Ian Mortimer

Società	Posizione	Fine
ARBUTUS BIOPHARMA CORPORATION	Director of Finance/CFO	01/10/2013
Perimeter Medical Imaging, Inc. Perimeter Medical Imaging, Inc. Medical SpecialtiesHealth Technology Perimeter Medical Imaging, Inc. provides medical services. It develops, patents and commercializes surgical imaging tools that allow surgeons, radiologists, and pathologists to assess microscopic tissue structures during surgical procedures. It offers OTIS Optical Tissue Imaging Console, OTIS Tissue Immobilization System, OTIS Proprietary Imaging Atlas, and Next Generation OTIS AI Tissue Assessment Algorithms. The company was founded by Elizabeth Munro, David Rempel, Andrew Berkeley, Arsen R. Hajian, and Gordon Cheung in 2013 and is headquartered in Toronto, Canada.	Director/Board Member	-
APPILI THERAPEUTICS INC.	Chairman	-

Vedi nel dettaglio l'esperienza di Ian Mortimer

Formazione di Ian Mortimer

Queen's University	Masters Business Admin
University of British Columbia	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ian Mortimer

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	4
ARBUTUS BIOPHARMA CORPORATION	Health Technology
XENON PHARMACEUTICALS INC.	Health Technology
APPILI THERAPEUTICS INC.	Health Technology
PERIMETER MEDICAL IMAGING AI, INC.	Health Technology

Aziende private	2
Perimeter Medical Imaging, Inc. Perimeter Medical Imaging, Inc. Medical SpecialtiesHealth Technology Perimeter Medical Imaging, Inc. provides medical services. It develops, patents and commercializes surgical imaging tools that allow surgeons, radiologists, and pathologists to assess microscopic tissue structures during surgical procedures. It offers OTIS Optical Tissue Imaging Console, OTIS Tissue Immobilization System, OTIS Proprietary Imaging Atlas, and Next Generation OTIS AI Tissue Assessment Algorithms. The company was founded by Elizabeth Munro, David Rempel, Andrew Berkeley, Arsen R. Hajian, and Gordon Cheung in 2013 and is headquartered in Toronto, Canada.	Health Technology
Xenon Pharmaceuticals USA, Inc. Xenon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Xenon Pharmaceuticals USA, Inc. develops clinical-stage biopharmaceutical products. The company is headquartered in Boston, PA.	Health Technology